About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

WITHDRAWNNANCT02530606

Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer

This pilot clinical trial studies how well photoacoustic imaging works in detecting ovarian or fallopian tube cancer. Photoacoustic imaging is an imaging method that uses lasers to light up tissue, an...

Lead sponsor: Stanford University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Stanford University

PRIMARY OBJECTIVES: I. To assess the performance of photoacoustic imaging (PAI) in detection of ovarian cancer in a clinical setting and to help improve the design of the next generation hand held PAI probe. SECONDARY OBJECTIVES: I. To evaluate vasculature and oxygen saturation in lesions based on PAI-measurements. OUTLINE: Patients undergo PAI over 15-30 minutes prior to the ovarian excision.

Age

18 - 80 years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•Patients must be undergoing ovarian resection
•Ability to understand and the willingness to sign a written informed consent document

Exclusion Criteria

•Patients who have had primary surgical excision
•Pregnant or lactating women

Related studies

RECRUITINGPhase 1

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

NCT06964009 · Ovarian Cancer, Ovarian Carcinoma, and more

RECRUITINGPhase 2

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

NCT05969860 · Advanced Anal Carcinoma, Advanced Biliary Tract Carcinoma, and more

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.

NCT06476808 · High-grade Serous Ovarian Carcinoma (HGSOC), Uterine Serous Carcinoma (USC), and more

REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

NCT06710548 · Ovarian Cancer, Advanced Ovarian Carcinoma, and more

RECRUITINGPhase 2

Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations

NCT04550494 · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 28, 2018Terms

Trial snapshot

StatusWITHDRAWN

PhaseNA

Enrollment—

Start dateSep 2016

Last updatedNov 28, 2018

Condition

Fallopian Tube Carcinoma Ovarian Carcinoma

Locations shown

Stanford University, School of Medicine

Palo Alto, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 28, 2018Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions